Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survival
Open Access
- 20 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 14 (21) , 3179-3189
- https://doi.org/10.1093/hmg/ddi349
Abstract
Mutations in the immunoglobulin mu binding protein-2 ( Ighmbp2 ) gene cause motor neuron disease and dilated cardiomyopathy (DCM) in the neuromuscular degeneration ( nmd ) mouse and spinal muscular atrophy with respiratory distress (SMARD1) in humans. To investigate the role of IGHMBP2 in the pathogenesis of DCM, we generated transgenic mice expressing the full-length Ighmbp2 cDNA specifically in myocytes under the control of the mouse titin promoter. This tissue-specific transgene increased the lifespan of nmd mice up to 8-fold by preventing primary DCM and showed complete functional correction as measured by ECG, echocardiography and plasma creatine kinase-MB. Double-transgenic nmd mice expressing Ighmbp2 both in myocytes and in neurons display correction of both DCM and motor neuron disease, resulting in an essentially wild-type appearance. Additionally, quantitative trait locus (QTL) analysis was undertaken to identify genetic modifier loci responsible for the preservation of cardiac function and a marked delay in the onset of cardiomyopathy in a CAST/EiJ backcross population. Three major CAST-derived cardiac modifiers of nmd were identified on chromosomes 9, 10 and 16, which account for over 26% of the genetic variance and that continue to suppress the exacerbation of cardiomyopathy, otherwise resulting in early death, as incipient B6.CAST congenics. Overall, our results verify the tissue-specific requirement for IGHMBP2 in cardiomyocyte maintenance and survival and describe genetic modifiers that can alter the course of DCM through cardiac functional adaptation and physical remodeling in response to changes in load and respiratory demand.Keywords
This publication has 27 references indexed in Scilit:
- Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1)Human Molecular Genetics, 2004
- Long-Term Observations of Patients with Infantile Spinal Muscular Atrophy with Respiratory Distress Type 1 (SMARD1)Neuropediatrics, 2004
- Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathyHuman Molecular Genetics, 2004
- At the Crossroads of Myocardial SignalingCirculation Research, 2004
- Balancing Contractility and Energy Production: The Role of Myocyte Enhancer Factor 2 (MEF2) in Cardiac HypertrophyRecent Progress in Hormone Research, 2004
- Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1)Annals of Neurology, 2003
- Multiple quantitative trait loci modify the heart failure phenotype in murine cardiomyopathyHuman Molecular Genetics, 2003
- Genetic Modifier Loci Affecting Survival and Cardiac Function in Murine Dilated CardiomyopathyCirculation, 2002
- Dilated Cardiomyopathy. Concepts Derived From Gene Deficient and Transgenic Animal Models.Circulation Journal, 2002
- From the Sarcomere to the Nucleus: Role of Genetics and Signaling in Structural Heart DiseaseAnnual Review of Genomics and Human Genetics, 2000